collection
Collections Top Papers for 2018 - Neurolog...

Top Papers for 2018 - Neurology

Top Papers for 2018 - Neurology

https://read.qxmd.com/read/29367334/2018-guidelines-for-the-early-management-of-patients-with-acute-ischemic-stroke-a-guideline-for-healthcare-professionals-from-the-american-heart-association-american-stroke-association
#1
REVIEW
William J Powers, Alejandro A Rabinstein, Teri Ackerson, Opeolu M Adeoye, Nicholas C Bambakidis, Kyra Becker, José Biller, Michael Brown, Bart M Demaerschalk, Brian Hoh, Edward C Jauch, Chelsea S Kidwell, Thabele M Leslie-Mazwi, Bruce Ovbiagele, Phillip A Scott, Kevin N Sheth, Andrew M Southerland, Deborah V Summers, David L Tirschwell
BACKGROUND AND PURPOSE: The purpose of these guidelines is to provide an up-to-date comprehensive set of recommendations for clinicians caring for adult patients with acute arterial ischemic stroke in a single document. The intended audiences are prehospital care providers, physicians, allied health professionals, and hospital administrators. These guidelines supersede the 2013 guidelines and subsequent updates. METHODS: Members of the writing group were appointed by the American Heart Association Stroke Council's Scientific Statements Oversight Committee, representing various areas of medical expertise...
March 2018: Stroke; a Journal of Cerebral Circulation
https://read.qxmd.com/read/29903905/idiopathic-intracranial-hypertension-consensus-guidelines-on-management
#2
REVIEW
Susan P Mollan, Brendan Davies, Nick C Silver, Simon Shaw, Conor L Mallucci, Benjamin R Wakerley, Anita Krishnan, Swarupsinh V Chavda, Satheesh Ramalingam, Julie Edwards, Krystal Hemmings, Michelle Williamson, Michael A Burdon, Ghaniah Hassan-Smith, Kathleen Digre, Grant T Liu, Rigmor Højland Jensen, Alexandra J Sinclair
UNLABELLED: The aim was to capture interdisciplinary expertise from a large group of clinicians, reflecting practice from across the UK and further, to inform subsequent development of a national consensus guidance for optimal management of idiopathic intracranial hypertension (IIH). METHODS: Between September 2015 and October 2017, a specialist interest group including neurology, neurosurgery, neuroradiology, ophthalmology, nursing, primary care doctors and patient representatives met...
October 2018: Journal of Neurology, Neurosurgery, and Psychiatry
https://read.qxmd.com/read/30415934/timing-of-anticoagulation-after-recent-ischaemic-stroke-in-patients-with-atrial-fibrillation
#3
REVIEW
David J Seiffge, David J Werring, Maurizio Paciaroni, Jesse Dawson, Steven Warach, Truman J Milling, Stefan T Engelter, Urs Fischer, Bo Norrving
BACKGROUND: About 13-26% of all acute ischaemic strokes are related to non-valvular atrial fibrillation, the most common cardiac arrhythmia globally. Deciding when to initiate oral anticoagulation in patients with non-valvular atrial fibrillation is a longstanding, common, and unresolved clinical challenge. Although the risk of early recurrent ischaemic stroke is high in this population, early oral anticoagulation is suspected to increase the risk of potentially harmful intracranial haemorrhage, including haemorrhagic transformation of the infarct...
January 2019: Lancet Neurology
https://read.qxmd.com/read/30037921/clinical-reasoning-a-patient-with-multiple-cranial-nerve-palsies-and-areflexic-paraparesis
#4
JOURNAL ARTICLE
Ravindra Kumar Garg, Imran Rizvi, Hardeep Singh Malhotra, Manan Mayur Mehta, Mili Jain, Madhu Mati Goel, Ravi Uniyal, Neeraj Kumar
No abstract text is available yet for this article.
July 24, 2018: Neurology
https://read.qxmd.com/read/29352526/ectrims-ean-guideline-on-the-pharmacological-treatment-of-people-with-multiple-sclerosis
#5
JOURNAL ARTICLE
X Montalban, R Gold, A J Thompson, S Otero-Romero, M P Amato, D Chandraratna, M Clanet, G Comi, T Derfuss, F Fazekas, H P Hartung, E Havrdova, B Hemmer, L Kappos, R Liblau, C Lubetzki, E Marcus, D H Miller, T Olsson, S Pilling, K Selmaj, A Siva, P S Sorensen, M P Sormani, C Thalheim, H Wiendl, F Zipp
BACKGROUND AND PURPOSE: Multiple sclerosis (MS) is a complex disease of the central nervous system. As new drugs are becoming available, knowledge on diagnosis and treatment must continuously evolve. There is therefore a need for a reference tool compiling current data on benefit and safety, to aid professionals in treatment decisions and use of resources across Europe. The European Committee of Treatment and Research in Multiple Sclerosis (ECTRIMS) and the European Academy of Neurology (EAN) have joined forces to meet this need...
February 2018: European Journal of Neurology
https://read.qxmd.com/read/29934921/magnetic-resonance-imaging-of-arterial-stroke-mimics-a-pictorial-review
#6
REVIEW
Gilles Adam, Marine Ferrier, Sofia Patsoura, Raluca Gramada, Zuzana Meluchova, Vanessa Cazzola, Jean Darcourt, Christophe Cognard, Alain Viguier, Fabrice Bonneville
Acute ischaemic stroke represents the most common cause of new sudden neurological deficit, but other diseases mimicking stroke happen in about one-third of the cases. Magnetic resonance imaging (MRI) is the best technique to identify those 'stroke mimics'. In this article, we propose a diagnostic approach of those stroke mimics on MRI according to an algorithm based on diffusion-weighted imaging (DWI), which can be abnormal or normal, followed by the results of other common additional MRI sequences, such as T2 with gradient recalled echo weighted imaging (T2-GRE) and fluid-attenuated inversion recovery (FLAIR)...
October 2018: Insights Into Imaging
https://read.qxmd.com/read/29399043/treatment-strategies-for-autoimmune-encephalitis
#7
REVIEW
Yong-Won Shin, Soon-Tae Lee, Kyung-Il Park, Keun-Hwa Jung, Ki-Young Jung, Sang Kun Lee, Kon Chu
Autoimmune encephalitis is one of the most rapidly growing research topics in neurology. Along with discoveries of novel antibodies associated with the disease, clinical experience and outcomes with diverse immunotherapeutic agents in the treatment of autoimmune encephalitis are accumulating. Retrospective observations indicate that early aggressive treatment is associated with better functional outcomes and fewer relapses. Immune response to first-line immunotherapeutic agents (corticosteroids, intravenous immunoglobulin, plasma exchange, and immunoadsorption) is fair, but approximately half or more of patients are administered second-line immunotherapy (rituximab and cyclophosphamide)...
2018: Therapeutic Advances in Neurological Disorders
https://read.qxmd.com/read/29275977/diagnosis-of-multiple-sclerosis-2017-revisions-of-the-mcdonald-criteria
#8
REVIEW
Alan J Thompson, Brenda L Banwell, Frederik Barkhof, William M Carroll, Timothy Coetzee, Giancarlo Comi, Jorge Correale, Franz Fazekas, Massimo Filippi, Mark S Freedman, Kazuo Fujihara, Steven L Galetta, Hans Peter Hartung, Ludwig Kappos, Fred D Lublin, Ruth Ann Marrie, Aaron E Miller, David H Miller, Xavier Montalban, Ellen M Mowry, Per Soelberg Sorensen, Mar Tintoré, Anthony L Traboulsee, Maria Trojano, Bernard M J Uitdehaag, Sandra Vukusic, Emmanuelle Waubant, Brian G Weinshenker, Stephen C Reingold, Jeffrey A Cohen
The 2010 McDonald criteria for the diagnosis of multiple sclerosis are widely used in research and clinical practice. Scientific advances in the past 7 years suggest that they might no longer provide the most up-to-date guidance for clinicians and researchers. The International Panel on Diagnosis of Multiple Sclerosis reviewed the 2010 McDonald criteria and recommended revisions. The 2017 McDonald criteria continue to apply primarily to patients experiencing a typical clinically isolated syndrome, define what is needed to fulfil dissemination in time and space of lesions in the CNS, and stress the need for no better explanation for the presentation...
February 2018: Lancet Neurology
https://read.qxmd.com/read/29661908/teaching-neuroimages-dwi-and-eeg-findings-in-creutzfeldt-jakob-disease
#9
JOURNAL ARTICLE
Aravind Ganesh, Lisa C Hoyte, Yahya Agha-Khani, Michael M C Yeung
No abstract text is available yet for this article.
April 17, 2018: Neurology
https://read.qxmd.com/read/30447971/-no-actually-it-is-not-a-headache
#10
JOURNAL ARTICLE
Jules Morgan
No abstract text is available yet for this article.
February 2020: Lancet Neurology
https://read.qxmd.com/read/29760005/clinical-reasoning-progressive-cognitive-decline-cerebellar-ataxia-recurrent-myoclonus-and-epilepsy
#11
JOURNAL ARTICLE
Fei Xiao, Jingchuan Fan, Jiaze Tan, Xue-Feng Wang
No abstract text is available yet for this article.
May 15, 2018: Neurology
https://read.qxmd.com/read/30284037/spinocerebellar-ataxia-an-update
#12
REVIEW
Roisin Sullivan, Wai Yan Yau, Emer O'Connor, Henry Houlden
Spinocerebellar ataxia (SCA) is a heterogeneous group of neurodegenerative ataxic disorders with autosomal dominant inheritance. We aim to provide an update on the recent clinical and scientific progresses in SCA where numerous novel genes have been identified with next-generation sequencing techniques. The main disease mechanisms of these SCAs include toxic RNA gain-of-function, mitochondrial dysfunction, channelopathies, autophagy and transcription dysregulation. Recent studies have also demonstrated the importance of DNA repair pathways in modifying SCA with CAG expansions...
February 2019: Journal of Neurology
https://read.qxmd.com/read/30154234/periprocedural-antithrombotic-management-for-lumbar-puncture-association-of-british-neurologists-clinical-guideline
#13
REVIEW
Katherine Claire Dodd, Hedley C A Emsley, Michael J R Desborough, Suresh K Chhetri
Lumbar puncture (LP) is an important and frequently performed invasive procedure for the diagnosis and management of neurological conditions. There is little in the neurological literature on the topic of periprocedural management of antithrombotics in patients undergoing LP. Current practice is therefore largely extrapolated from guidelines produced by anaesthetic bodies on neuraxial anaesthesia, haematology groups advising on periprocedural management of antiplatelet agents and anticoagulants, and by neuroradiology on imaging-guided spinal procedures...
December 2018: Practical Neurology
https://read.qxmd.com/read/30201756/teaching-video-neuroimages-a-treatable-rare-cause-of-chorea
#14
JOURNAL ARTICLE
Malco Rossi, Angel Cammarota, Marcelo Merello, Martin Nogues
No abstract text is available yet for this article.
September 11, 2018: Neurology
https://read.qxmd.com/read/29572353/remember-the-retina-retinal-disorders-presenting-to-neurologists
#15
REVIEW
Zhaleh Khaleeli, William R Tucker, Lana Del Porto, Jonathan D Virgo, Gordon T Plant
General neurologists and stroke specialists are regularly referred cases of visual disturbance by general practitioners, emergency doctors and even ophthalmologists. Particularly when the referral comes from ophthalmologists, our assessment tends to focus on the optic nerve; however, retinal conditions may mimic optic neuropathy and are easily missed. Their diagnosis requires specific investigations that are rarely available in a neurology clinic. This article focuses on how a general neurologist can identify retinal problems from the clinical assessment and how to proceed with initial investigations...
April 2018: Practical Neurology
https://read.qxmd.com/read/30074496/advances-in-management-of-guillain-barr%C3%A3-syndrome
#16
REVIEW
Alex Y Doets, Bart C Jacobs, Pieter A van Doorn
PURPOSE OF REVIEW: The clinical presentation of Guillain-Barré syndrome (GBS) is highly variable, which can make the diagnosis challenging. Intravenous immunoglobulin (IVIg) and plasma exchange are the cornerstones of treatment since decades. But despite these treatments, 25% initially progress in muscle weakness, 25% require artificial ventilation, 20% is still not able to walk independently after 6 months, and 2-5% die, emphasizing the need for better treatment. We summarize new developments regarding the diagnosis, prognosis, and management of GBS...
October 2018: Current Opinion in Neurology
https://read.qxmd.com/read/29413316/igg4-related-disease-of-the-central-and-peripheral-nervous-systems
#17
REVIEW
Mahmoud A AbdelRazek, Nagagopal Venna, John H Stone
IgG4-related disease can involve nearly any organ system, including the central and peripheral nervous systems. The pathology findings are consistent from organ to organ, but careful clinicopathological correlation is necessary to establish the diagnosis. Many non-neurological and neurological inflammatory conditions, previously regarded as idiopathic in nature, are now recognised to fall within the spectrum of IgG4-related disease. The condition is highly treatable, but probably remains substantially under-recognised...
February 2018: Lancet Neurology
https://read.qxmd.com/read/29766754/antiplatelet-therapy-after-ischemic-stroke-or-tia
#18
EDITORIAL
James C Grotta
New England Journal of Medicine, Volume 379, Issue 3, Page 291-292, July 2018.
July 19, 2018: New England Journal of Medicine
https://read.qxmd.com/read/30291424/cerebral-small-vessel-disease-neuroimaging-markers-and-clinical-implication
#19
REVIEW
Xiaodong Chen, Jihui Wang, Yilong Shan, Wei Cai, Sanxin Liu, Mengyan Hu, Siyuan Liao, Xuehong Huang, Bingjun Zhang, Yuge Wang, Zhengqi Lu
Cerebral small vessel disease (CSVD) is a broad category of cerebrovascular diseases which primarily affect the perforating arterioles, capillaries and venules with multiple distinct etiologies. In spite of distinctive pathogenesis, CSVD shares similar neuroimaging markers, including recent small subcortical infarct, lacune of presumed vascular origin, white matter hyperintensity of presumed vascular origin, perivascular space and cerebral microbleeds. The radiological features of neuroimaging markers are indicative for etiological analysis...
October 2019: Journal of Neurology
https://read.qxmd.com/read/29868890/current-concepts-in-diagnosis-and-treatment-of-functional-neurological-disorders
#20
REVIEW
Alberto J Espay, Selma Aybek, Alan Carson, Mark J Edwards, Laura H Goldstein, Mark Hallett, Kathrin LaFaver, W Curt LaFrance, Anthony E Lang, Tim Nicholson, Glenn Nielsen, Markus Reuber, Valerie Voon, Jon Stone, Francesca Morgante
IMPORTANCE: Functional neurological disorders (FND) are common sources of disability in medicine. Patients have often been misdiagnosed, correctly diagnosed after lengthy delays, and/or subjected to poorly delivered diagnoses that prevent diagnostic understanding and lead to inappropriate treatments, iatrogenic harm, unnecessary and costly evaluations, and poor outcomes. OBSERVATIONS: Functional Neurological Symptom Disorder/Conversion Disorder was adopted by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, replacing the term psychogenic with functional and removing the criterion of psychological stress as a prerequisite for FND...
September 1, 2018: JAMA Neurology
label_collection
label_collection
14595
1
2
2018-12-19 16:37:38
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.